![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-a071b1c825adeab85a3b5c9c1b379bb27f6b420db41edc7dd33e62f65b25dc7a.jpg)
Bevacizumab for the Treatment of Patients with Brain Radionecrosis
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.